Skip to main content
Top
Published in: Malaria Journal 1/2011

Open Access 01-12-2011 | Research

Poor quality vital anti-malarials in Africa - an urgent neglected public health priority

Authors: Paul N Newton, Michael D Green, Dallas C Mildenhall, Aline Plançon, Henry Nettey, Leonard Nyadong, Dana M Hostetler, Isabel Swamidoss, Glenn A Harris, Kristen Powell, Ans E Timmermans, Abdinasir A Amin, Stephen K Opuni, Serge Barbereau, Claude Faurant, Ray CW Soong, Kevin Faure, Jonarthan Thevanayagam, Peter Fernandes, Harparkash Kaur, Brian Angus, Kasia Stepniewska, Philippe J Guerin, Facundo M Fernández

Published in: Malaria Journal | Issue 1/2011

Login to get access

Abstract

Background

Plasmodium falciparum malaria remains a major public health problem. A vital component of malaria control rests on the availability of good quality artemisinin-derivative based combination therapy (ACT) at the correct dose. However, there are increasing reports of poor quality anti-malarials in Africa.

Methods

Seven collections of artemisinin derivative monotherapies, ACT and halofantrine anti-malarials of suspicious quality were collected in 2002/10 in eleven African countries and in Asia en route to Africa. Packaging, chemical composition (high performance liquid chromatography, direct ionization mass spectrometry, X-ray diffractometry, stable isotope analysis) and botanical investigations were performed.

Results

Counterfeit artesunate containing chloroquine, counterfeit dihydroartemisinin (DHA) containing paracetamol (acetaminophen), counterfeit DHA-piperaquine containing sildenafil, counterfeit artemether-lumefantrine containing pyrimethamine, counterfeit halofantrine containing artemisinin, and substandard/counterfeit or degraded artesunate and artesunate+amodiaquine in eight countries are described. Pollen analysis was consistent with manufacture of counterfeits in eastern Asia. These data do not allow estimation of the frequency of poor quality anti-malarials in Africa.

Conclusions

Criminals are producing diverse harmful anti-malarial counterfeits with important public health consequences. The presence of artesunate monotherapy, substandard and/or degraded and counterfeit medicines containing sub-therapeutic amounts of unexpected anti-malarials will engender drug resistance. With the threatening spread of artemisinin resistance to Africa, much greater investment is required to ensure the quality of ACTs and removal of artemisinin monotherapies. The International Health Regulations may need to be invoked to counter these serious public health problems.
Appendix
Available only for authorised users
Literature
3.
go back to reference White NJ: Qinghaosu (artemisinin): the price of success. Science. 2008, 320: 330-334. 10.1126/science.1155165.CrossRefPubMed White NJ: Qinghaosu (artemisinin): the price of success. Science. 2008, 320: 330-334. 10.1126/science.1155165.CrossRefPubMed
6.
go back to reference Newton PN, McGready R, Fernández F, Green MD, Sunjio M, Bruneton C, Phanouvong S, Millet P, Whitty CJ, Talisuna AO, Proux S, Christophel EM, Malenga G, Singhasivanon P, Bojang K, Kaur H, Palmer K, Day NPJ, Greenwood BM, Nosten F, White NJ: Manslaughter by fake artesunate in Asia-will Africa be next?. PLoS Medicine. 2006, 3: e197-10.1371/journal.pmed.0030197.PubMedCentralCrossRefPubMed Newton PN, McGready R, Fernández F, Green MD, Sunjio M, Bruneton C, Phanouvong S, Millet P, Whitty CJ, Talisuna AO, Proux S, Christophel EM, Malenga G, Singhasivanon P, Bojang K, Kaur H, Palmer K, Day NPJ, Greenwood BM, Nosten F, White NJ: Manslaughter by fake artesunate in Asia-will Africa be next?. PLoS Medicine. 2006, 3: e197-10.1371/journal.pmed.0030197.PubMedCentralCrossRefPubMed
8.
go back to reference Caudron JM, Ford N, Henkens M, Macé C, Kiddle-Monroe R, Pinel J: Substandard medicines in resource-poor settings: a problem that can no longer be ignored. Trop Med Int Health. 2008, 13: 1062-72. 10.1111/j.1365-3156.2008.02106.x.CrossRefPubMed Caudron JM, Ford N, Henkens M, Macé C, Kiddle-Monroe R, Pinel J: Substandard medicines in resource-poor settings: a problem that can no longer be ignored. Trop Med Int Health. 2008, 13: 1062-72. 10.1111/j.1365-3156.2008.02106.x.CrossRefPubMed
9.
go back to reference Leslie T, Kaur H, Mohammed N, Kolaczinski K, Ord RL, Rowland M: Epidemic of Plasmodium falciparum malaria involving substandard antimalarial drugs, Pakistan, 2003. Emerg Infect Dis. 2009, 15: 1753-1759.PubMedCentralCrossRefPubMed Leslie T, Kaur H, Mohammed N, Kolaczinski K, Ord RL, Rowland M: Epidemic of Plasmodium falciparum malaria involving substandard antimalarial drugs, Pakistan, 2003. Emerg Infect Dis. 2009, 15: 1753-1759.PubMedCentralCrossRefPubMed
10.
go back to reference Newton PN, Fernández FM, Green MD, Primo-Carpenter J, White NJ: Counterfeit and substandard anti-infectives in developing countries. Antimicrobial Resistance in Developing Countries. Edited by: Sosa AJ, Byarugaba DK, Amábile-Cuevas CF, Hsueh P-R, Kariuki S, Okeke IN. 2009, New York, Springer, 413-443. Newton PN, Fernández FM, Green MD, Primo-Carpenter J, White NJ: Counterfeit and substandard anti-infectives in developing countries. Antimicrobial Resistance in Developing Countries. Edited by: Sosa AJ, Byarugaba DK, Amábile-Cuevas CF, Hsueh P-R, Kariuki S, Okeke IN. 2009, New York, Springer, 413-443.
11.
go back to reference Keoluangkhot V, Green M, Nyadong L, Fernández F, Mayxay M, Newton PN: Impaired clinical response in a patient with uncomplicated falciparum malaria who received poor quality and underdosed intramuscular artemether. Am J Trop Med Hyg. 2008, 78: 552-555.PubMed Keoluangkhot V, Green M, Nyadong L, Fernández F, Mayxay M, Newton PN: Impaired clinical response in a patient with uncomplicated falciparum malaria who received poor quality and underdosed intramuscular artemether. Am J Trop Med Hyg. 2008, 78: 552-555.PubMed
12.
go back to reference Amin AA, Kokwaro GO: Antimalarial drug quality in Africa. J Clin Phar Ther. 2007, 32: 429-440. 10.1111/j.1365-2710.2007.00847.x.CrossRef Amin AA, Kokwaro GO: Antimalarial drug quality in Africa. J Clin Phar Ther. 2007, 32: 429-440. 10.1111/j.1365-2710.2007.00847.x.CrossRef
13.
go back to reference White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, Lee SJ, Dondorp AM, White LJ, Day NP: Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. Malar J. 2009, 8: 253-10.1186/1475-2875-8-253.PubMedCentralCrossRefPubMed White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, Lee SJ, Dondorp AM, White LJ, Day NP: Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. Malar J. 2009, 8: 253-10.1186/1475-2875-8-253.PubMedCentralCrossRefPubMed
14.
go back to reference Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T: Intercontinental spread of pyrimethamine-resistant malaria. Science. 2004, 305: 1124-10.1126/science.1098876.CrossRefPubMed Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T: Intercontinental spread of pyrimethamine-resistant malaria. Science. 2004, 305: 1124-10.1126/science.1098876.CrossRefPubMed
15.
go back to reference Ariey F, Fandeur T, Durand R, Randrianarivelojosia M, Jambou R, Legrand E, Ekala MT, Bouchier C, Cojean S, Duchemin JB, Robert V, Le Bras J, Mercereau-Puijalon O: Invasion of Africa by a single pfcrt allele of South East Asian type. Malar J. 2006, 5: 34-10.1186/1475-2875-5-34.PubMedCentralCrossRefPubMed Ariey F, Fandeur T, Durand R, Randrianarivelojosia M, Jambou R, Legrand E, Ekala MT, Bouchier C, Cojean S, Duchemin JB, Robert V, Le Bras J, Mercereau-Puijalon O: Invasion of Africa by a single pfcrt allele of South East Asian type. Malar J. 2006, 5: 34-10.1186/1475-2875-5-34.PubMedCentralCrossRefPubMed
16.
go back to reference Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ: Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009, 355: 1959-1966. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ: Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009, 355: 1959-1966.
17.
go back to reference Bate R, Coticelli P, Tren R, Attaran A: Antimalarial drug quality in the most severely malarious parts of Africa - a six country study. PLoS One. 2008, 3: e2132-10.1371/journal.pone.0002132.PubMedCentralCrossRefPubMed Bate R, Coticelli P, Tren R, Attaran A: Antimalarial drug quality in the most severely malarious parts of Africa - a six country study. PLoS One. 2008, 3: e2132-10.1371/journal.pone.0002132.PubMedCentralCrossRefPubMed
18.
go back to reference Hope KE: Beware of fake Co-Artem malaria tabs on the market. The Ghanaian Times. July 10th 2009 Hope KE: Beware of fake Co-Artem malaria tabs on the market. The Ghanaian Times. July 10th 2009
19.
go back to reference United States Pharmacopeia: Counterfeit antimalarial drug discovered in Ghana with aid of USP Drug Quality and Information Program. 2009, Press release, USP, Available at http://www.usp.org/worldwide/. Accessed 12 March 2011 United States Pharmacopeia: Counterfeit antimalarial drug discovered in Ghana with aid of USP Drug Quality and Information Program. 2009, Press release, USP, Available at http://​www.​usp.​org/​worldwide/​. Accessed 12 March 2011
20.
go back to reference Udoh F: NAFDAC impounds N10 Million Fake Malaria Drugs. AllAfrica.com. 21 Jan 2010 Udoh F: NAFDAC impounds N10 Million Fake Malaria Drugs. AllAfrica.com. 21 Jan 2010
21.
go back to reference Udoh F: Nigeria: NAFDAC impounds consignments of fake drugs valued at N500 Million. AllAfrica.com. 10 June 2010 Udoh F: Nigeria: NAFDAC impounds consignments of fake drugs valued at N500 Million. AllAfrica.com. 10 June 2010
25.
go back to reference Newton PN, Lee SJ, Goodman C, Fernández FM, Yeung S, Phanouvong S, Kaur H, Amin AA, Whitty CJM, Kokwaro GO, Lindegårdh N, Lukulay P, White LJ, Day NPJ, Green MD, White NJ: Guidelines for field surveys of the quality of medicines: a proposal. PLoS Med. 2009, 6: e1000052-PubMedCentralCrossRef Newton PN, Lee SJ, Goodman C, Fernández FM, Yeung S, Phanouvong S, Kaur H, Amin AA, Whitty CJM, Kokwaro GO, Lindegårdh N, Lukulay P, White LJ, Day NPJ, Green MD, White NJ: Guidelines for field surveys of the quality of medicines: a proposal. PLoS Med. 2009, 6: e1000052-PubMedCentralCrossRef
26.
go back to reference Newton PN, Fernández FM, Plançon A, Mildenhall DC, Green MD, Ziyong L, Christophel EM, Phanouvong S, Howells S, McIntosh E, Laurin P, Blum N, Hampton CY, Faure K, Nyadong L, Soong SWR, Santoso B, Zhiguang W, Newton J, Palmer K: A Collaborative Epidemiological Investigation into the Criminal Fake Artesunate Trade in South East Asia. PLoS Med. 2008, 5: e32-10.1371/journal.pmed.0050032.PubMedCentralCrossRefPubMed Newton PN, Fernández FM, Plançon A, Mildenhall DC, Green MD, Ziyong L, Christophel EM, Phanouvong S, Howells S, McIntosh E, Laurin P, Blum N, Hampton CY, Faure K, Nyadong L, Soong SWR, Santoso B, Zhiguang W, Newton J, Palmer K: A Collaborative Epidemiological Investigation into the Criminal Fake Artesunate Trade in South East Asia. PLoS Med. 2008, 5: e32-10.1371/journal.pmed.0050032.PubMedCentralCrossRefPubMed
27.
go back to reference Green MD, Nettey H, Villalva Rojas O, Pamanivong C, Khounsaknalath L, Ortiz MG, Newton PN, Fernández FM, Vongsack L, Manolin O: Use of refractometry and colorimetry as field methods to rapidly assess antimalarial drug quality. J Pharm Biomed Anal. 2007, 43: 105-110. 10.1016/j.jpba.2006.06.047.CrossRefPubMed Green MD, Nettey H, Villalva Rojas O, Pamanivong C, Khounsaknalath L, Ortiz MG, Newton PN, Fernández FM, Vongsack L, Manolin O: Use of refractometry and colorimetry as field methods to rapidly assess antimalarial drug quality. J Pharm Biomed Anal. 2007, 43: 105-110. 10.1016/j.jpba.2006.06.047.CrossRefPubMed
28.
go back to reference Fernández FM, Cody RB, Green MD, Hampton CY, McGready R, Sengaloundeth S, White NJ, Newton PN: Characterization of solid counterfeit drug samples by desorption electrospray ionization and direct-analysis-in-real-time coupled to time-of-flight mass spectrometry. Chem Med Chem. 2006, 1: 702-705.CrossRefPubMed Fernández FM, Cody RB, Green MD, Hampton CY, McGready R, Sengaloundeth S, White NJ, Newton PN: Characterization of solid counterfeit drug samples by desorption electrospray ionization and direct-analysis-in-real-time coupled to time-of-flight mass spectrometry. Chem Med Chem. 2006, 1: 702-705.CrossRefPubMed
29.
go back to reference Nyadong L, Green MD, De Jesus VR, Newton PN, Fernández FM: Reactive desorption electrospray ionization linear ion trap mass spectrometry of latest-generation counterfeit antimalarials via noncovalent complex formation. Anal Chem. 2007, 79: 2150-2157. 10.1021/ac062205h.CrossRefPubMed Nyadong L, Green MD, De Jesus VR, Newton PN, Fernández FM: Reactive desorption electrospray ionization linear ion trap mass spectrometry of latest-generation counterfeit antimalarials via noncovalent complex formation. Anal Chem. 2007, 79: 2150-2157. 10.1021/ac062205h.CrossRefPubMed
30.
go back to reference The United States Pharmacopeia: The United States Pharmacopeia. 2005, Washington, D.C., USA. The United States Pharmacopeial Convention The United States Pharmacopeia: The United States Pharmacopeia. 2005, Washington, D.C., USA. The United States Pharmacopeial Convention
32.
go back to reference Ioset JR, Kaur H: Simple field assays to check quality of current artemisinin-based antimalarial combination formulations. PLoS One. 2009, 4: e7270-10.1371/journal.pone.0007270.PubMedCentralCrossRefPubMed Ioset JR, Kaur H: Simple field assays to check quality of current artemisinin-based antimalarial combination formulations. PLoS One. 2009, 4: e7270-10.1371/journal.pone.0007270.PubMedCentralCrossRefPubMed
33.
go back to reference Wolff JC, Thomson LA, Eckers C: Identification of the 'wrong' active pharmaceutical ingredient in a counterfeit Halfan drug product using accurate mass electrospray ionization mass spectrometry, accurate mass tandem mass spectrometry and liquid chromatography/mass spectrometry. Rapid Comm Mass Spect. 2003, 17: 215-221. 10.1002/rcm.893.CrossRef Wolff JC, Thomson LA, Eckers C: Identification of the 'wrong' active pharmaceutical ingredient in a counterfeit Halfan drug product using accurate mass electrospray ionization mass spectrometry, accurate mass tandem mass spectrometry and liquid chromatography/mass spectrometry. Rapid Comm Mass Spect. 2003, 17: 215-221. 10.1002/rcm.893.CrossRef
37.
go back to reference Sengaloundeth S, Green MD, Fernández FM, Manolin O, Phommavong K, Insixiengmay V, Hampton CY, Nyadong L, Mildenhall DC, Hostetler D, Khounsaknalath L, Vongsack L, Phompida S, Vanisaveth V, Syhakhang L, Newton PN: A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR-implications for therapeutic failure and drug resistance. Malar J. 2009, 8: 172-10.1186/1475-2875-8-172.PubMedCentralCrossRefPubMed Sengaloundeth S, Green MD, Fernández FM, Manolin O, Phommavong K, Insixiengmay V, Hampton CY, Nyadong L, Mildenhall DC, Hostetler D, Khounsaknalath L, Vongsack L, Phompida S, Vanisaveth V, Syhakhang L, Newton PN: A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR-implications for therapeutic failure and drug resistance. Malar J. 2009, 8: 172-10.1186/1475-2875-8-172.PubMedCentralCrossRefPubMed
38.
go back to reference Anon: British National Formulary No 56. 2008, BMJ Group and RPS Publishing, London Anon: British National Formulary No 56. 2008, BMJ Group and RPS Publishing, London
41.
go back to reference Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, Taylor TE, Plowe CV: Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med. 2006, 361: 455-467. Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, Taylor TE, Plowe CV: Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med. 2006, 361: 455-467.
43.
go back to reference Edike T: NAFDAC raids fake drug label printing house. Vanguard (Lagos). 12 Dec 2003 Edike T: NAFDAC raids fake drug label printing house. Vanguard (Lagos). 12 Dec 2003
44.
go back to reference Anon: Combating counterfeit drugs. Lancet. 2008, 371: 1551-10.1016/S0140-6736(08)60663-7.CrossRef Anon: Combating counterfeit drugs. Lancet. 2008, 371: 1551-10.1016/S0140-6736(08)60663-7.CrossRef
48.
go back to reference Yeung S, Van Damme W, Socheat D, White NJ, Mills A: Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Malar J. 2008, 7: 96-10.1186/1475-2875-7-96.PubMedCentralCrossRefPubMed Yeung S, Van Damme W, Socheat D, White NJ, Mills A: Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Malar J. 2008, 7: 96-10.1186/1475-2875-7-96.PubMedCentralCrossRefPubMed
51.
go back to reference Attaran A, Bate R, Kendall M: Why and how to make an international crime of medicine counterfeiting. J Int Criminal Justice. 2011, doi:10.1093/jicj/mqr005 Attaran A, Bate R, Kendall M: Why and how to make an international crime of medicine counterfeiting. J Int Criminal Justice. 2011, doi:10.1093/jicj/mqr005
Metadata
Title
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority
Authors
Paul N Newton
Michael D Green
Dallas C Mildenhall
Aline Plançon
Henry Nettey
Leonard Nyadong
Dana M Hostetler
Isabel Swamidoss
Glenn A Harris
Kristen Powell
Ans E Timmermans
Abdinasir A Amin
Stephen K Opuni
Serge Barbereau
Claude Faurant
Ray CW Soong
Kevin Faure
Jonarthan Thevanayagam
Peter Fernandes
Harparkash Kaur
Brian Angus
Kasia Stepniewska
Philippe J Guerin
Facundo M Fernández
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2011
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-10-352

Other articles of this Issue 1/2011

Malaria Journal 1/2011 Go to the issue